To obtain long-term capital appreciation by investing primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or whose securities are traded on a U.S. exchange, which are engaged in the design, development, manufacturing and distribution of products or services in the health care sectors. The Fund will invest in a diversified portfolio, which will mainly include securities in the medical technology, biotechnology, health care and pharmaceutical sectors.
Also available in Class F
Minimum Initial Investment:
Distribution of Earnings:
In the month of December, income and capital gains accumulated to date are distributed.
Pre-Authorized Chequing Investment (PAC) or Group RRSP:
$50 minimum investment for monthly, quarterly, semi-annual or annual deposit.
Systematic Withdrawal Plan:
With minimum initial account value of $10,000. Withdrawals may be made monthly, quarterly, semi-annually or annually. $50 minimum.
Annual Management Fee (excluding applicable taxes): 2.50%
Annualized Management Expense Ratio (including applicable taxes) as at August 31, 2018: 3.02%†
|Front-End Load Option||ATL1161|
|Back-End Load Option||ATL1162|
|Low Load Option||ATL2162|
|Inception Date:||November 2, 1996|
|Assets Under Management (000’s)
|Wellington Management Canada LLC|
Wellington Management Group is an employee-owned private firm. Wellington's professionals operate within teams. Each focuses on specific investment approaches and conducts research within their own area of expertise, which is shared across teams. The firm covers global equity and fixed income, markets and includes multi-strategy, specialty and alternative investment approaches, each with a well-articulated investment philosophy and process. The firm's most distinctive strength is its proprietary, independent research.
Headquartered in Boston, Massachusetts, it has a global presence with offices located across North America, Europe, Asia and Australia.
Jean M. Hynes, CFA
As an analyst in Global Industry Research, Jean specializes in the pharmaceutical and biotechnology industries. She conducts fundamental analysis on the companies within her industries and makes buy/sell recommendations to portfolio managers based on her findings and market conditions. In addition, Jean manages the Vanguard Healthcare Fund and is a member of the health care team that manages other health and biotechnology sector mutual funds and hedge funds.
Jean holds a BA in economics from Wellesley College (1991). She joined Wellington Management upon her graduation. She holds the Chartered Financial Analyst designation, and is a member of the CFA Institute and the Boston Security Analysts Society.
|3 mo||6 mo||1 yr||3 yrs||5 yrs||10 yrs||YTD||Since
|Calendar Year Performance|
Value of $10,000 invested since inception
The rate of return or mathematical table shown is used only to illustrate the effects of the compound growth rate and is not intended to reflect future values of the fund or returns on investment in the fund.
†Please refer to the Annual/Interim Management Reports of Fund Performance for further details.
Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the Renaissance Investments family of funds simplified prospectus before investing. The indicated rates of return are the historical annual compounded total returns for the class A units including changes in unit value and reinvestment of all distributions, but do not take into account sales, redemption, distribution or optional charges or income taxes payable by any unitholder that would have reduced returns. Mutual funds are not guaranteed. The values of many mutual funds change frequently. Past performance may not be repeated.